Valeant CEO 'disappointed' in Allergan poison pill: CNBC
April 23, 2014 at 08:05 AM EDT
(Reuters) - The chief executive officer of Valeant Pharmaceuticals, which made a $47 billion unsolicited offer for competitor Allergan Inc. on Tuesday, said during an interview on CNBC that he was "disappointed" with Allergan's so-called poison pill.